Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2005 Oct 19;2005(4):CD002897.
doi: 10.1002/14651858.CD002897.pub2.

Intra-operative mitomycin C for glaucoma surgery

M Wilkins  1 , A Indar, R Wormald
Affiliations
Meta-Analysis

Intra-operative mitomycin C for glaucoma surgery

M Wilkins et al. Cochrane Database Syst Rev. .

Abstract

Background: Trabeculectomy is performed as a treatment for glaucoma to lower the intraocular pressure (IOP). Mitomycin C (MMC) is an antimetabolite used during the initial stages of a trabeculectomy to prevent excessive postoperative scarring and thus reduce the risk of failure.

Objectives: To assess the effects of intraoperative MMC compared to placebo in trabeculectomy.

Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group Trials Register) on The Cochrane Library (Issue 1, 2005), MEDLINE (1966 to March 2005), EMBASE (1985 to 20 March 2005), SIGLE (1980 to December 2004), the National Research Register (Issue 1, 2005), LILACS (29 March 2005) and reference lists of articles. We also contacted researchers in the field.

Selection criteria: We included randomised trials of intraoperative MMC compared to placebo in trabeculectomy surgery.

Data collection and analysis: Two authors independently assessed trial quality and extracted data. We contacted trial investigators for missing information.

Main results: Eleven trials, involving a total of 698 participants, were included. The trials enrolled three types of participants (high risk of failure, trabeculectomy combined with cataract surgery, no previous surgical intervention). Mitomycin C appears to reduce the relative risk of failure of trabeculectomy both in eyes at high risk of failure (relative risk 0.32, 95% confidence interval 0.20 to 0.53) and those undergoing surgery for the first time (relative risk 0.29, 95% confidence interval 0.16 to 0.53). No significant effect on failure was noted in the group undergoing trabeculectomy combined with cataract extraction. Mean IOP was significantly reduced at 12 months in all three participant groups receiving MMC compared to placebo. No significant increase in permanent sight-threatening complications was detected. However, none of the trials were large enough or of sufficient duration to address the long-term risk of bleb infection and endophthalmitis which has been reported in observational studies. Some evidence exists that MMC increases the risk of cataract.

Authors' conclusions: Intraoperative MMC reduces the risk of surgical failure in eyes that have undergone no previous surgery and in eyes at high risk of failure. Compared to placebo it reduces mean IOP at 12 months in all groups of participants in this review. Apart from an increase in cataract formation following MMC, there was insufficient power to detect any increase in other serious side effects such as endophthalmitis.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
2
2
Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Andreanos 1997 {published data only}
    1. Andreanos D, Georgopoulos GT, Vergados J, Papaconstantinou D, Liokis N, Theodossiadis P. Clinical evaluation of the effect of mitomycin‐C in re‐operation for primary open angle glaucoma. European Journal of Ophthalmology 1997;7(1):49‐54. - PubMed
Carlson 1997 {published data only}
    1. Carlson DW, Alward WL, Barad JP, Zimmerman MB, Carney BL. A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. Ophthalmology 1997;104(4):719‐24. - PubMed
Cohen 1996 {published data only}
    1. Cohen JS, Greff LJ, Novack GD, Wind BE. A placebo‐controlled, double‐masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996;103(11):1934‐42. - PubMed
Costa 1996 {published data only}
    1. Costa VP, Comegno PE, Vasconcelos JP, Malta RF, Jose NK. Low‐dose mitomycin C trabeculectomy in patients with advanced glaucoma. Journal of Glaucoma 1996;5(3):193‐9. - PubMed
Martini 1997 {published data only}
    1. Martini E, Laffi GL, Sprovieri C, Scorolli L. Low‐dosage mitomycin C as an adjunct to trabeculectomy. A prospective controlled study. European Journal of Ophthalmology 1997;7(1):40‐8. - PubMed
Robin 1997 {published data only}
    1. Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD, Selvaraj S, et al. A long‐term dose‐response study of mitomycin in glaucoma filtration surgery. Archives of Ophthalmology 1997;115(8):969‐74. - PubMed
Shin 1995 {published data only}
    1. Shin DH, Simone PA, Song MS, Reed SY, Juzych MS, Kim C, et al. Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. Ophthalmology 1995;102(10):1550‐8. - PubMed
Shin 1998 {published data only}
    1. Shin DH, Kim YY, Sheth N, Ren J, Shah M, Kim C, et al. The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure. Ophthalmology 1998;105(4):740‐5. - PubMed
Szymanski 1997 {published data only}
    1. Szymanski A, Gierek Lapinska A, Koziak M, Gierek Ciaciura S. A fluorophotometric study of corneal endothelium after trabeculectomy using different concentrations of Mitomycin‐C. International Ophthalmology 1996;20(1‐3):95‐9. - PubMed
Turacli 1996 {published data only}
    1. Turacli E, Gunduz K, Aktan G, Tamer C. A comparative clinical trial of mitomycin C and cyclosporin A in trabeculectomy. European Journal of Ophthalmology 1996;6(4):398‐401. - PubMed
Wu 1996 {published data only}
    1. Wu L, Yin J. The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis. Chinese Journal of Ophthalmology 1996;32(1):32‐4. - PubMed

References to studies excluded from this review

Chen 2001 {published data only}
    1. Chen X, Liu X, Wu D. Application of mitomycin c and 5‐fluorouracil in the glaucoma filtering surgery. Chinese Ophthalmic Research 2001;19(4):347‐9.
Shin 1996 {published data only}
    1. Shin DH, Hughes BA, Song MS, Kim C, Yang KJ, Shah MI, et al. Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure. Ophthalmology 1996;103(11):1925‐33. - PubMed

References to studies awaiting assessment

Reibaldi 2008 {published data only}
    1. Reibaldi A, Uva MG, Longo A. Nine‐year follow‐up of trabeculectomy with or without low‐dosage mitomycin‐c in primary open‐angle glaucoma. British Journal of Ophthalmology 2008;92(12):1666‐70. - PubMed

Additional references

AGIS 1998a
    1. AGIS. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven‐year results. Ophthalmology 1998;105(7):1146‐64. - PubMed
Broadway 1994
    1. Broadway D, Grierson I, Hitchings R. Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important?. British Journal of Ophthalmology 1994;78(6):466‐75. - PMC - PubMed
Burr 2004
    1. Burr J, Azuara‐Blanco A, Avenell A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD004399.pub2] - DOI - PubMed
Chen 1990
    1. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin‐C in refractory glaucoma. Journal of Ocular Pharmacology 1990;6(3):175‐82. - PubMed
Chen 1997
    1. Chen P, Yamamoto T, Sawada A, Parrish R, Kitazawa Y. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. Journal of Glaucoma 1997;6(3):192‐6. - PubMed
CNTG 1998a
    1. Collaborative Normal‐Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal‐tension glaucoma. American Journal of Ophthalmology 1998;126(4):498‐505. - PubMed
CNTG 1998b
    1. Collaborative Normal‐Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal‐tension glaucoma and patients with therapeutically reduced pressures. American Journal of Ophthalmology 1998;126(4):487‐97. - PubMed
Costa 1993
    1. Costa VP, Wilson RP, Moster MR, Schmidt CM, Gandham S. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surgery 1993;24(6):389‐94. - PubMed
EMGT 2002
    1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 2002;120(10):1268‐79. - PubMed
Glanville 2006
    1. Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6. - PMC - PubMed
Greenfield 1996
    1. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr. Endophthalmitis after filtering surgery with mitomycin. Archives of Ophthalmology 1996;114(8):943‐9. - PubMed
Higginbotham 1996
    1. Higginbotham EJ, Stevens RK, Musch DC, Karp KO, Lichter PR, Bergstrom TJ, et al. Bleb‐related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103(4):650‐6. - PubMed
Khaw 1992a
    1. Khaw PT, Sherwood MB, Doyle JW, Smith MF, Grierson I, McGorray S, et al. Intraoperative and post operative treatment with 5‐fluorouracil and mitomycin‐c: long term effects in vivo on subconjunctival and scleral fibroblasts. International Ophthalmology 1992;16(4‐5):381‐5. - PubMed
Khaw 1992b
    1. Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G. Five‐minute treatments with fluorouracil, floxuridine, and mitomycin have long‐term effects on human Tenon's capsule fibroblasts. Archives of Ophthalmology 1992;110(8):1150‐4. - PubMed
Lavin 1990
    1. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Archives of Ophthalmology 1990;108(11):1543‐8. - PubMed
Maier 2005
    1. Maier PC, Funk J, Schwarzer G, Antes G, Falck‐Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta‐analysis of randomised controlled trials. BMJ 2005;331(7509):134. - PMC - PubMed
Membrey 2000
    1. Membrey WL, Poinoosawmy DP, Bunce C, Hitchings RA. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications. British Journal of Ophthalmology 2000;84(6):586‐90. - PMC - PubMed
OHTS 2002
    1. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open‐angle glaucoma. Archives of Ophthalmology 2002;120(6):701‐13. - PubMed
Parrish 1992
    1. Parrish RK 2d. Who should receive antimetabolites after filtering surgery. Archives of Ophthalmology 1992;110(8):1069‐71. - PubMed
Rossetti 1993
    1. Rossetti L, Marchetti I, Orzalesi N, Scorpiglione N, Torri V, Liberati A. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?. Archives of Ophthalmology 1993;111(1):96‐103. - PubMed
Shields 1993
    1. Shields MB. Another reevaluation of combined cataract and glaucoma surgery. American Journal of Ophthalmology 1993;115(6):806‐11. - PubMed
Skuta 1987
    1. Skuta GL, Parrish RK 2nd. Wound healing in glaucoma filtering surgery. Survey of Ophthalmology 1987;32(3):149‐70. - PubMed
Suner 1997
    1. Suner IJ, Greenfield DS, Miller MP, Nicolela MT, Palmberg PF. Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology 1997;104(2):207‐14. - PubMed
Wilkins 2000
    1. Wilkins MR, Occleston NL, Kotecha A, Waters L, Khaw PT. Sponge delivery variables and tissue levels of 5‐fluorouracil. British Journal of Ophthalmology 2000;84(1):92‐7. - PMC - PubMed
Wormald 2001
    1. Wormald R, Wilkins MR, Bunce C. Postoperative 5‐Fluorouracil for glaucoma surgery. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001132] - PubMed
Zacharia 1993
    1. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. American Journal of Ophthalmology 1993;116(3):314‐26. - PubMed

MeSH terms